Back Back
Tagrisso 80mg Tablet
Get Price Quote
Osimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
80 Mg Osimertinib Tablets
Get Price Quote
10 Box (MOQ)
Best Deals from Osimertinib Tablet
Tagrisso 80mg Tablet
Get Price Quote
10 Pack (MOQ)
Tagrisso 80mg Tablet
152,000 Per Box
100 Box (MOQ)
Tagrisso 80mg Tablet
118,920 Per Strip
1000 Strip (MOQ)
Tagrisso 80mg Tablet is a protein kinase inhibitor used in the treatment of non-small cell lung cancer. It is used in the treatment of adult patients who have certain estimated glomerular filtration rate (EGFR) mutations.
